140 results
8-K
EX-4.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof
8-K
EX-10.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Investor Party under … and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance or non-performance
8-K
EX-4.2
18q7orw2xis8
6 May 24
Entry into a Material Definitive Agreement
4:11pm
424B5
h27qh
3 May 24
Prospectus supplement for primary offering
4:05pm